FDAnews
www.fdanews.com/articles/84497-ventana-reports-fourth-quarter-results

VENTANA REPORTS FOURTH QUARTER RESULTS

February 10, 2006

Ventana Medical Systems, Inc. today reported sales of $54.3 million for the quarter ending December 31, 2005, a 13% increase over the fourth quarter of 2004. The Company reported GAAP net income for the fourth quarter of $10.6 million, or $0.29 per diluted share, compared with GAAP net income of $8.6 million, or $0.24 per share, in the fourth quarter of 2004. "Reagents and other revenues grew 19% versus last year's fourth quarter, while instrument revenue decreased by 9% in the quarter versus last year," commented Christopher Gleeson, Ventana's President and Chief Executive Officer.
MarketWire